Pharmaceutics chair elected to leadership in AAPS

Michael A. Repka

ichael A. Repka, chair of pharmaceutics, is the new vice chair of the Formulation Design and Development Section of the American Association of Pharmaceutical Scientists.

Repka was elected vice chair during the association's annual meeting in Washington, D.C., in October. His election—a precursor to terms as chair-elect, chair and past chair—represents a four-year commitment.

"It is an honor and a privilege to be elected vice chair of this section," Repka said. "I am humbled to represent such a significant number of AAPS members. I look forward to serving this group during the next four years."

With 4,200 members, the FDD Section is AAPS's largest and enables its members to share experimental results, consider new formulation and dosage form technologies, and discuss issues and concerns regarding the design and development of formulations and drug products.

With Repka's election, the School of Pharmacy holds leadership positions in the most visible professional pharmacy associations in the country. Brian Crabtree, professor of pharmacy practice, is president of the American Association of Colleges of Pharmacy, and Walt Chambliss, professor of pharmaceutics, serves on the board of trustees of the American Pharmacists Association and is president of the APhA-Academy of Research and Science.

"We are delighted that Dr. Repka has been elected to serve as FDD vice chair for AAPS," said David D. Allen, pharmacy dean. "Service is pivotal to our mission at the Ole Miss School of Pharmacy, and our students, faculty and staff continually seek opportunities to give back. We look forward to Mike's leadership in this role."

AAPS—a professional association with approximately 12,000 members employed in industry, academia, government and research institutes worldwide—provides an international forum for the exchange of knowledge among scientists to enhance their contributions to public health.